report
antivir
activ
human
cytomegaloviru
certain
dietari
flavonoid
like
biochem
mechan
action
nine
ten
evalu
flavonoid
block
hcmv
replic
concentr
significantli
lower
produc
cytotox
grow
stationari
phase
host
cell
baicalein
potent
inhibitor
seri
ic
includ
posit
control
ganciclovir
baicalein
genistein
chosen
model
compound
studi
antivir
mechan
action
seri
flavonoid
significantli
reduc
level
hcmv
earli
late
protein
well
viral
dna
synthesi
baicalein
reduc
level
hcmv
immediateearli
protein
nearli
background
level
genistein
antivir
effect
genistein
baicalein
fulli
revers
cell
cultur
preincub
concentr
viru
stock
either
flavonoid
inhibit
hcmv
replic
suggest
baicalein
directli
inactiv
viru
particl
baicalein
function
block
epiderm
growth
factor
receptor
tyrosin
kinas
activ
hcmv
nuclear
transloc
genistein
h
post
infect
hcmvinfect
cell
treat
genistein
continu
express
immediateearli
protein
effici
phosphoryl
howev
hcmv
induct
nfb
increas
level
cell
cycl
regulatori
proteinsev
associ
immediateearli
protein
function
absent
data
suggest
primari
mechan
action
baicalein
may
block
hcmv
infect
entri
primari
mechan
action
genistein
may
block
hcmv
immediateearli
protein
function
major
popul
infect
human
cytomegaloviru
hcmv
yet
small
fraction
infect
person
suffer
notabl
clinic
manifest
alford
britt
hcmv
caus
morbid
mortal
immunocompromis
individu
transplant
recipi
acquir
immun
defici
syndrom
patient
landolfo
et
al
davi
et
al
hcmv
surfac
glycoprotein
ligand
interact
cellular
receptor
produc
multipl
cell
growth
inflammatori
signal
reactiv
hcmv
immediateearli
protein
express
ever
et
mani
pathway
hcmv
employ
activ
cell
growth
inflammatori
event
requir
viral
replic
may
use
target
antivir
drug
develop
current
approv
drug
treatment
hcmv
infect
includ
viral
dna
polymeras
inhibitor
foscarnet
cidofovir
ganciclovir
prodrug
valganciclovir
griffith
compound
virostat
block
late
stage
hcmv
replic
prevent
viral
induct
multipl
cell
activ
event
thu
may
use
investig
potenti
new
drug
treatment
hcmv
infect
goal
mind
investig
potenti
antihcmv
activ
flavonoid
natur
occur
flavonoid
found
dietari
botan
sourc
mani
propos
respons
health
benefit
certain
folk
remedi
dietari
supplement
beecher
number
biolog
properti
describ
propos
variou
flavonoid
includ
antioxid
antiinflammatori
antiprolif
vasculoprotect
effect
gabor
formica
regelson
specif
modul
activ
number
cellular
enzym
includ
inhibit
protein
kinas
middleton
et
al
two
properti
flavonoid
predict
possibl
antivir
activ
hcmv
first
replic
multipl
virus
inhibit
variou
flavonoid
genistein
activ
bovin
herpesviru
type
akula
et
al
inhibit
herp
simplex
viru
hsv
hcmv
polioviru
hayashi
et
al
quercetin
activ
herp
simplex
adeno
respiratori
syncyti
rsv
rou
sarcoma
sindbi
pseudorabi
parainfluenza
virus
chiang
et
al
formica
regelson
luteolin
quercetin
inhibit
sar
coronaviru
yi
et
al
kaempferol
deriv
inhibit
hsv
hcmv
polioviru
amoro
et
al
mitrocotsa
et
al
robin
et
al
antivir
activ
sever
herpesvirus
respiratori
virus
report
seri
biflavonoid
lin
et
al
sever
glycosyl
flavonoid
activ
rsv
influenza
wei
et
al
second
flavonoid
affect
signal
transduct
pathway
requir
hcmv
replic
effect
variou
flavonoid
upon
receptor
tyrosin
kinas
akt
mapk
transcript
factor
prostaglandin
vari
accord
compound
compound
concentr
stimulu
cell
type
formica
regelson
middleton
et
al
obtain
commerci
avail
dietari
flavonoid
test
inhibitor
hcmv
replic
report
describ
select
inhibit
hcmv
nine
flavonoid
effort
character
antihcmv
mode
action
two
model
compound
baicalein
genistein
flavonoid
ganciclovir
gcv
orthonitrophenyl
onpg
purchas
sigmaaldrich
st
loui
mo
purchas
calbiochem
la
jolla
ca
stock
solut
drug
compound
either
mgml
prepar
dimethylsulfoxid
dmso
store
c
oligonucleotid
synthes
nucleic
acid
core
facil
lineberg
comprehens
cancer
center
univers
north
carolina
chapel
hill
antibodi
specif
hcmv
protein
prepar
laboratori
describ
previous
kowalik
et
al
et
al
wing
et
al
antibodi
purchas
oncogen
san
diego
ca
antibodi
egfr
cyclin
e
pcna
gift
dr
yue
xiong
santa
cruz
santa
cruz
ca
antibodi
purchas
chemicon
temecula
ca
correspond
fluoresceinconjug
secondari
antibodi
santa
cruz
horseradish
peroxidas
hrp
conjug
antibodi
phosphotyrosin
purchas
bd
bioscienc
appropri
secondari
hrpconjug
antibodi
purchas
calbiochem
sigmaaldrich
oncogen
primari
human
embryon
lung
fibroblast
hel
purchas
american
tissu
cultur
collect
atcc
manassa
va
cultur
dulbecco
modifi
eagl
media
dmem
gibco
brl
gaithersburg
md
supplement
fetal
bovin
serum
fb
unitsml
penicillin
gml
streptomycin
experi
hel
cell
perform
passag
stock
town
strain
hcmv
passag
prepar
describ
previous
huang
et
al
unless
otherwis
specifi
cell
grown
confluenc
serum
starv
h
dmem
prior
hcmv
infect
multipl
infect
moi
plaqueform
unit
pfu
cell
purifi
sucros
cushion
elimin
cytokin
growth
factor
contamin
plaqu
reduct
studi
viru
cell
free
infect
cultur
supernat
use
indic
colorimetr
antivir
assay
variant
hcmv
spaet
mocarski
purchas
atcc
supernat
infect
cell
cultur
day
cytopath
effect
use
directli
infect
cell
cultur
variou
concentr
drug
ad
confluent
serumstarv
hel
fibroblast
plate
h
c
atmospher
co
cell
infect
hcmv
town
strain
moi
approxim
pfucel
media
indic
drug
concentr
total
volum
mlwell
seven
day
post
infect
l
infect
cultur
supernat
appropri
dilut
well
plate
use
inocul
correspond
cultur
plate
follow
adsorpt
inocul
remov
methylcellulos
methocel
overlay
contain
dmem
fb
ad
seven
ten
day
post
infect
cell
fix
paraformaldehyd
pb
stain
crystal
violet
plaqu
count
invert
light
microscopi
data
quantifi
percentag
plaqu
well
lack
drug
posit
control
experi
plaqu
present
posit
control
well
preincub
revers
studi
serial
dilut
supernat
prepar
plate
quantit
titer
procedur
describ
elsewher
prichard
et
al
modifi
procedur
employ
one
freezethaw
cycl
prior
titer
addit
freezethaw
cycl
result
significantli
lower
viru
yield
antivir
colorimetr
assay
modifi
procedur
describ
elsewher
hippenmey
dilworth
assay
use
recombin
viru
hcmv
escherichia
coli
gene
control
hcmv
major
earli
gene
promot
integr
viral
genom
homolog
recombin
spaet
mocarski
viral
gene
express
replic
cell
measur
colorimetr
assay
variou
concentr
drug
dmem
ad
confluent
serumstarv
hel
fibroblast
plate
plate
incub
h
c
atmospher
co
cell
infect
equal
volum
dmem
contain
hcmv
pfucel
seventytwo
hour
later
supernat
remov
cell
monolay
rins
phosphatebuff
salin
pb
well
ad
l
lysi
solut
glycerol
triton
mm
dtt
mm
edta
mm
tri
ph
plate
incub
c
min
well
ad
l
freshli
prepar
graviti
filter
substrat
solut
mg
onpg
ad
ml
buffer
consist
mm
na
hpo
mm
nah
po
mm
mgcl
mm
plate
incub
room
temperatur
rt
min
reaction
stop
ad
lwell
na
co
optic
densiti
determin
nm
use
micropl
reader
follow
subtract
absorb
valu
determin
neg
control
uninfect
cell
wellsplat
data
quantifi
percentag
averag
absorb
determin
posit
control
infect
cell
wellsplat
absorb
posit
control
typic
au
absorb
neg
control
au
determin
drug
cytotox
static
hel
monolay
cell
grown
confluenc
plate
serumstarv
h
prior
addit
variou
concentr
compound
describ
plaqu
reduct
assay
except
viru
inoculum
methylcellulos
omit
cytotox
grow
hel
monolay
determin
similarli
except
cell
serumstarv
approxim
confluent
drug
ad
seventytwo
hour
post
treatment
select
drug
concentr
cell
viabil
assess
tetrazolium
colorimetr
dye
assay
kit
accord
manufactur
instruct
promega
madison
wi
concentr
drug
percentag
absorb
nm
determin
compar
neg
control
well
equival
amount
dmso
ad
weislow
et
al
data
plot
percent
inhibit
versu
drug
concentr
concentr
curv
linearli
regress
determin
inhibitori
concentr
valu
ic
ic
present
mean
standard
deviat
multipl
independ
experi
indic
legend
tabl
baicalein
genistein
ad
make
final
concentr
respect
mm
dish
confluent
serumstarv
hel
compound
present
h
throughout
infect
cell
infect
hcmv
incub
c
atmospher
co
harvest
monolay
harvest
indic
time
scrape
dish
sodium
dodecyl
sulfat
sd
sampl
buffer
sampl
boil
load
onto
sdspolyacrylamid
gel
protein
separ
electrophoresi
transfer
immobilonp
membran
millipor
bedford
membran
block
h
wv
nonfat
dri
milk
bovin
serum
albumin
use
block
membran
detect
phosphoryl
protein
pb
pbst
membran
probe
dilut
primari
antibodi
overnight
c
blot
wash
probe
hors
radish
peroxidaseconjug
secondari
antibodi
wash
develop
enhanc
chemiluminesc
ecl
accord
manufactur
instruct
amersham
bioscienc
corp
piscataway
nj
rel
protein
level
quantifi
film
scan
tiff
file
use
imagequ
amersham
softwar
quantif
hcmv
dna
synthesi
perform
describ
previous
johnson
et
al
hel
cell
grown
confluenc
plate
serumstarv
h
infect
pfucel
hcmv
presenc
absenc
compound
hpi
individu
well
harvest
remov
cell
cultur
medium
replac
ml
pb
freez
c
plate
thaw
ml
denatur
buffer
consist
nacl
naoh
ad
well
min
ml
neutral
buffer
consist
nacl
tri
hcl
ph
ad
well
min
sampl
transfer
immobil
nitrocellulos
membran
use
minifold
apparatu
schleicher
schuell
keen
nh
bake
c
h
vacuum
nonspecif
bind
block
incub
denhardt
ssc
vv
formamid
wv
sd
gml
salmon
sperm
dna
c
h
membran
probe
block
buffer
h
c
heat
denatur
purifi
town
genom
dna
label
p
datp
mp
biomed
irvin
ca
nick
translat
accord
manufactur
instruct
invitrogen
carlsbad
ca
follow
wash
membran
develop
autoradiographi
one
hour
prior
infect
drug
ad
mm
dish
hel
cell
subsequ
infect
mockinfect
hcmv
protein
experi
media
replac
phosphatefre
dmem
gibco
brl
spike
ci
po
mp
biomed
h
label
period
prior
harvest
variou
time
post
infect
cell
harvest
scrape
icecold
pb
resuspend
ml
ip
buffer
consist
mm
nacl
mm
naf
mm
navo
nonidet
mm
tri
ph
proteas
inhibitor
cocktail
sigma
microfug
vial
sampl
freezethaw
incub
ice
min
occasion
vortex
debri
remov
centrifug
equival
protein
content
supernat
determin
colorimetr
assay
biorad
hercul
ca
sampl
incub
g
primari
antibodi
rock
c
h
twenti
microlit
protein
gsepharos
slurri
amersham
ad
sampl
incub
h
c
gentl
agit
sampl
centrifug
supernat
remov
pellet
wash
four
time
c
pbst
bead
boil
sdspage
load
buffer
supernat
load
onto
polyacrylamid
gel
electrophores
transfer
immobilonp
membran
describ
phosphoryl
egfr
experi
membran
analyz
first
antibodi
phosphotyrosin
strip
probe
antibodi
egfr
phosphoryl
experi
membran
autoradiograph
probe
antibodi
confirm
protein
ident
reactiv
band
extract
prepar
describ
previous
yurochko
et
al
yurochko
et
al
briefli
mockinfect
infect
hel
fibroblast
without
flavonoid
collect
scrape
cell
monolay
mm
dish
icecold
pb
wash
centrifug
cell
resuspend
incub
min
ice
l
cytoplasm
isol
buffer
consist
mm
hepe
ph
mm
kcl
mm
edta
mm
dtt
proteas
inhibitor
cocktail
sigma
sampl
centrifug
cytoplasm
supernat
remov
nuclear
pellet
wash
cytoplasm
extract
buffer
minu
incub
min
ice
l
nuclear
isol
buffer
consist
mm
tri
ph
mm
nacl
mm
mgcl
mm
edta
mm
dtt
vv
glycerol
proteas
inhibitor
cocktail
sampl
centrifug
desir
supernat
extract
store
c
emsa
perform
describ
previous
yurochko
et
al
yurochko
et
al
briefli
equal
amount
nuclear
extract
determin
colorimetr
protein
content
assay
biorad
aliquot
place
ice
one
two
microgram
poli
didc
plabel
doublestrand
deoxi
oligonucleotid
nfb
specif
probe
yurochko
et
al
bind
buffer
mm
tri
hcl
mm
nacl
mm
mgcl
mm
edta
vv
glycerol
mm
dtt
ad
final
volum
l
sampl
incub
min
rt
electrophores
polyacrylamid
gel
dri
analyz
autoradiographi
probe
label
anneal
complimentari
deoxi
oligonucleotid
fill
overhang
end
p
datp
hel
fibroblast
seed
onto
glass
chamber
slide
falcon
grown
confluenc
serum
starv
overnight
thirti
minut
prior
infect
slide
place
ice
ten
minut
prior
infect
media
chang
icecold
dmem
contain
baicalein
genistein
none
media
remov
replac
icecold
dmem
contain
pfucel
hcmv
presenc
absenc
drug
slide
incub
c
h
c
atmospher
co
h
well
wash
min
either
pb
pb
contain
drug
concentr
media
without
drug
ad
well
slide
incub
h
c
slide
wash
icecold
pb
min
simultan
fix
permeabil
methanol
c
min
slide
wash
pb
min
block
buffer
bb
consist
pb
fb
min
well
incub
antibodi
bb
min
wash
pb
min
bb
min
well
incub
fluoresceinconjug
secondari
antibodi
bb
min
wash
pb
min
gml
dapi
santa
cruz
pb
min
pb
min
slide
mount
molwiol
analyz
zeiss
axioskop
use
filter
dapi
fluorescein
examin
abil
panel
flavonoid
fig
inhibit
replic
hcmv
two
complementari
antivir
endpoint
measur
employ
titer
reduct
colorimetr
assay
colorimetr
assay
base
upon
activ
transgen
version
strain
express
enzym
hcmv
major
earli
promot
spaet
mocarski
nine
ten
compound
show
antivir
activ
concentr
least
one
antivir
assay
tabl
baicalein
potent
inhibitor
examin
includ
posit
control
ganciclovir
display
ic
colorimetr
assay
titer
reduct
assay
rule
possibl
antivir
activ
flavonoid
artifact
cytotox
employ
commerci
tetrazolium
colorimetr
dye
assay
measur
drug
effect
cell
viabil
significantli
higher
concentr
hcmvinhibitori
flavonoid
necessari
produc
cellular
cytotox
static
grow
hel
cell
tabl
chose
two
structur
differ
model
compound
studi
antivir
mode
action
seri
subsequ
experi
perform
gml
baicalein
genistein
gml
concentr
potent
inhibit
viral
replic
display
obviou
cytotox
cell
cultur
order
identifi
stage
hcmv
replic
specif
inhibit
flavonoid
determin
effect
upon
viral
protein
repres
immediateearli
earli
late
viral
gene
express
western
blot
analys
reveal
three
kinet
class
hcmv
protein
reduc
nearli
background
level
baicalein
fig
fifti
micromol
genistein
reproduc
result
slightli
lower
level
h
post
infect
hpi
level
sensit
genistein
never
reduc
sinc
present
prior
reason
mechan
action
genistein
might
direct
inhibit
protein
kinas
autophosphoryl
pajov
et
al
reproduc
detect
substanti
amount
phosphoryl
rel
total
presenc
absenc
genistein
fig
contrast
effect
upon
immediateearli
protein
genistein
treatment
result
unambigu
block
hcmv
earli
late
protein
flavonoid
reduc
protein
nearli
background
level
hpi
respect
fig
confirm
result
obtain
drug
effect
upon
hcmv
protein
measur
viral
dna
level
hcmvinfect
cell
treat
flavonoid
dot
southern
blot
employ
viral
dna
synthesi
inhibitor
ganciclovir
posit
control
mar
et
al
hcmv
dna
reduc
nearli
background
level
infect
cell
treat
baicalein
fig
similar
effect
ganciclovir
genistein
reproduc
inhibit
hcmv
dna
replic
approxim
hpi
assess
potenti
virucid
activ
baicalein
determin
effect
pretreat
infecti
viru
stock
flavonoid
stock
hcmv
preincub
either
media
drugcontain
media
h
later
use
infect
cell
pretreat
media
concentr
drug
equal
dilut
use
preincub
viru
antivir
effect
pretreat
virion
baicalein
ganciclovir
genistein
similar
pretreat
cell
effect
dilut
concentr
data
shown
examin
whether
antivir
effect
baicalein
genistein
could
revers
follow
remov
drug
sinc
flavonoid
block
hcmv
dna
synthesi
employ
dot
southern
blot
endpoint
assay
infect
cell
presenc
baicalein
genistein
hpi
media
replac
drugfre
media
sampl
harvest
day
day
presenc
flavonoid
day
releas
drug
pressur
fig
input
viru
experi
similar
fig
howev
film
expos
fig
signal
viru
control
would
satur
day
post
infect
upon
releas
genistein
inhibit
hcmv
dna
replic
resum
increas
time
delay
approxim
h
viru
control
suggest
genistein
block
occur
hpi
low
level
rebound
viral
dna
present
upon
releas
baicalein
inhibit
suggest
antivir
effect
baicalein
poorli
revers
similar
experi
employ
viru
titer
endpoint
perform
substanti
result
hcmvinfect
fibroblast
elsewher
shown
undergo
cell
cycl
arrest
jault
et
al
dittmer
mocarski
evidenc
increas
level
cyclindepend
kinas
cyclin
e
prolifer
cell
nuclear
antigen
pcna
well
cellular
dna
level
consist
block
either
g
g
jault
et
al
dittmer
mocarski
cell
cycl
arrest
reproduc
cell
transfect
wiebusch
hagemei
role
disrupt
varieti
cell
cycl
regulatori
pathway
castillo
et
al
hcmv
immediateearli
protein
induc
tumor
suppressor
protein
muganda
et
al
speir
et
al
level
may
provid
measur
immediateearli
protein
transactiv
measur
abil
baicalein
genistein
control
viral
dna
replic
inhibitor
ganciclovir
inhibit
hcmvmediat
cell
cycl
regulatori
protein
induct
hpi
immunoblot
fig
increas
steadyst
level
cyclin
e
pcna
affect
treatment
ganciclovir
activ
protein
hcmv
inhibit
baicalein
genistein
genistein
treatment
alway
result
full
inhibit
hcmv
induct
protein
fig
howev
none
increas
level
reflect
immediateearli
protein
compar
hcmv
posit
control
respons
genistein
fig
order
assess
possibl
genistein
might
act
inhibit
transactiv
function
hcmv
immediateearli
protein
measur
effect
upon
nfb
transcript
factor
activ
laboratori
previous
describ
biphas
induct
nfb
upon
hcmv
infect
immediateearli
protein
like
major
contributor
effect
hpi
yurochko
et
al
nfb
induc
hcmvinfect
fibroblast
compar
uninfect
fig
induct
absent
hcmvinfect
cell
treat
baicalein
genistein
sinc
antivir
properti
baicalein
appear
function
prior
hcmv
protein
express
perform
experi
assess
effect
upon
initi
event
viral
replic
cycl
egfr
autophosphoryl
receptorligand
event
requir
viru
replic
initi
hcmvinduc
cellular
signal
transduct
viru
entri
wang
et
al
examin
abil
flavonoid
block
hcmvmediat
phosphoryl
egfr
shortli
follow
infect
immunoprecipit
egfr
follow
western
blot
total
tyrosin
phosphoryl
form
reveal
similar
total
egfr
virusinfect
uninfect
cell
regardless
drug
treatment
fig
hcmvinduc
phosphoryl
reduc
background
level
baicalein
fig
genistein
fig
examin
effect
baicalein
genistein
upon
entri
nuclear
transloc
hcmv
particl
hel
fibroblast
infect
hcmv
nuclear
local
tegument
protein
examin
hpi
fluoresc
microscopi
hcmvposit
control
observ
cell
nuclei
fig
baicalein
genistein
block
effici
nuclear
accumul
data
indic
number
flavonoid
possess
antivir
activ
hcmv
concentr
produc
cytotox
tabl
suggest
seri
natur
product
synthet
deriv
may
provid
use
pharmacophor
futur
proprietari
antivir
other
report
genistein
inhibit
hcmv
replic
slobbevan
drunen
et
al
howev
endpoint
assay
limit
effect
genistein
upon
hcmv
protein
level
hpi
discrep
antivir
data
ic
valu
titer
reduct
assay
comparison
colorimetr
assay
particularli
antivir
potenc
posit
control
ganciclovir
compound
inhibit
hcmv
replic
stage
viral
dna
replic
via
inhibit
hcmvspecif
dna
polymeras
inhibit
immediateearli
earli
gene
express
express
report
fig
effect
flavonoid
upon
hcmv
nuclear
transloc
hel
fibroblast
infect
hcmv
presenc
absenc
baicalein
genistein
six
hpi
cell
fix
stain
viral
tegument
protein
green
nuclei
stain
dapi
blue
cell
examin
fluoresc
microscopi
enzym
hcmvinfect
cell
earli
promot
control
thu
colorimetr
assay
faith
measur
inhibitori
effect
certain
compound
act
dna
replic
l
stage
viru
replic
contrast
effect
upon
viral
dna
fig
titer
tabl
colorimetr
assay
detect
littl
antivir
activ
posit
control
ganciclovir
reproduc
ic
report
ganciclovir
origin
descript
assay
hippenmey
dilworth
adapt
assay
examin
ganciclovir
ten
time
nine
time
obtain
ic
tabl
data
shown
possibl
differ
infect
condit
respons
discrep
infect
fibroblast
centrifug
viru
pfucel
onto
trypsin
cell
pellet
infect
ad
supernat
viru
pfucel
media
adher
cell
infect
cell
hcmv
centrifug
elsewher
shown
acceler
viral
dna
replic
detect
instead
hpi
amplifi
fold
increas
hcmv
protein
stain
hcmv
replic
ho
et
al
gleav
et
al
other
report
use
moi
pfucel
adapt
hpi
assay
infect
without
centrifug
van
der
strate
et
al
shown
tabl
seri
compound
suggest
trend
toward
structureact
relationship
hcmv
inhibit
gener
flavon
activ
group
flavonoid
examin
among
flavon
flavonol
deriv
hydroxyl
posit
greater
antihcmv
activ
sinc
naringenin
essenti
inact
antivir
assay
possibl
antihcmv
activ
requir
aromat
conjug
coplanar
arrang
benzen
ring
baicalein
potent
compound
lost
activ
conjug
glucuron
acid
posit
baicalin
similarli
kaempferol
activ
hcmv
less
toxic
parent
compound
mitrocotsa
et
al
two
potent
select
compound
seri
baicalein
quercetin
arrang
hydroxyl
substitu
ring
well
unsubstitut
b
ring
toxic
compound
seri
luteolin
dihydroxyl
b
ring
investig
potenti
mechan
action
flavonoid
hcmv
began
check
effect
compound
upon
viral
protein
express
viral
dna
synthesi
result
fig
suggest
baicalein
oper
prior
hcmv
immediateearli
protein
express
genistein
oper
immediateearli
earli
protein
express
antivir
effect
genistein
baicalein
fulli
poorli
revers
respect
fig
howev
preincub
viru
baicalein
genistein
result
mark
inhibit
hcmv
suggest
baicalein
directli
inactiv
viru
particl
data
suggest
primari
mechan
action
baicalein
antivir
activ
hcmv
prevent
entri
target
kinas
activ
egfr
shown
previous
target
requir
hcmv
entri
cellular
activ
wang
et
al
surpris
genisteina
known
inhibitor
tyrosin
protein
kinas
activ
fig
genistein
ic
phosphoryl
histon
purifi
egfr
test
tube
ic
egfstimul
egfr
autophosphoryl
human
epidermoid
carcinoma
cell
akiyama
et
al
differ
experiment
condit
may
explain
discrep
addit
egf
hcmv
gb
glycoprotein
specif
recogn
differ
speci
erbb
homoand
heterooligom
wang
et
al
baicalein
describ
elsewher
specif
inhibitor
ic
valu
rang
nm
sekiya
okuda
cho
et
al
summarili
discard
possibl
requir
hcmv
entri
could
oper
prior
hcmv
activ
egfr
howev
direct
virion
interact
detect
hcmv
egfr
wang
et
al
receptor
tyrosin
kinas
capabl
act
upstream
lipoxygenas
seth
et
al
data
suggest
primari
mechan
action
genistein
antivir
activ
hcmv
block
immediateearli
protein
function
genistein
appear
prevent
earli
late
hcmv
gene
express
fig
immediateearli
protein
less
present
two
downstream
effector
system
cell
cycl
perturb
nfb
transcript
factor
induct
less
absent
upon
treatment
genistein
fig
genistein
reduc
level
greater
extent
fig
express
prior
transactiv
express
sambucetti
et
al
implic
possibl
target
genistein
affect
phosphoryl
fig
flavonoid
clearli
abund
mani
common
dietari
sourc
commerci
dietari
supplement
estim
person
high
soy
diet
steadyst
serum
level
genistein
adlercreutz
et
al
clear
flavonoid
gener
bioavail
dietari
sourc
maintain
steadyst
level
suffici
produc
human
benefit
maladi
issu
potenti
toxic
overlook
seek
justif
anecdot
document
health
benefit
flavonoid
consumpt
studi
support
inquiri
possibl
flavonoid
may
assist
clear
hcmv
infect
well
possibl
health
benefit
safeti
efficaci
demonstr
standard
achiev
barn
b
flavonoidrich
diet
natur
product
may
provid
may
continu
provid
wide
access
inexpens
altern
antivir
medicin
